Biopharmaceutical firm Shenzhen Readline Biotech has secured 500 million yuan ($68.8 million) in a Series C funding round participated by Green Pine Capital Partners and CoStone Capital.
Continue reading premium content with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
